Main Article Content


Objectives: To determine the prevalence of atherosclerosis in female systemic lupus erythematosus (SLE) patients aged below 40 years old and the factors correlated with carotid intima-media (CIM) thickening.

Methods: A cross-sectional study was conducted on 80 female SLE respondents aged below 40 years old who were either in- or outpatient of Cipto Mangunkusumo General Hospital, Jakarta. History of disease and treatment was taken, and laboratory test and  ultrasonography of the carotid artery to evaluate CIM thickness were performed.

Results: The prevalence of atherosclerosis was 40%, comprising of CIM thickening and/or presence of atherosclerotic plaque in the carotid artery. The median values of CIM thickness in the right common carotid artery, right carotid bulb, left common carotid artery, and left carotid bulb were 0.040 cm, 0.04535 cm, 0.0430 cm, and 0.047 cm, respectively. There was also a positive correlation reported of CIM thickness with increased age, the duration of SLE disease, and the duration of steroid treatment.

Conclusions: We found a positive correlation of CIM thickness with age, the duration of SLE disease, and the duration of steroid treatment in female SLE patients aged below 40 years.

Article Details

How to Cite
Sari, R. M., Kasjmir, Y. I., Antono, D., & Setiati, S. (2018). Atherosclerosis prevalence and the correlation between atherosclerosis risk factors and carotid intima-media thickness in below 40-year-old women with systemic lupus erythematosus. Indonesian Journal of Rheumatology, 2(1).


  1. Isbagio H, Albar Z, Kasjmir YI. Systemic lupus erythematosus [Lupus eritematosus sistemik]. In: Sudoyo AW, Setiyohadi B, Alwi I, Kolopaking MS, Setiati S, editors. Text book of internal medicine [Buku ajar ilmu penyakit dalam] . 4th ed. Jakarta: PIP; 2006. p. 1224–31.
  2. Lam GKW, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005;23:S120–S32.
  3. Hahn BH. Systemic lupus erythematosus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harison’s principles of internal medicine. 16th ed. New York: Mc Graw-Hill; 2005. p. 1950–67.
  4. Mc Mahoon M, Grossman J. Pathogenesis of atherosclerosis in lupus. In: JW Daniel, HH Bevra, editors. Dubois lupus erythematosus. 7th ed. Philadelpia: Lippincot Williams & Wilkins; 2007. p. 356–66.
  5. Swaak AJG, van den Brink HG, Smeenk RJT, Manger K, Kalden JR, Tosi S, et al. Systemic lupus erythematosus: clinical features in patients with disease duration of over 10 years, fi rst evaluation. Rheumatology 1999;38:953–8.
  6. Mattu A, Petrini J, Swencki S, Chaudhari C, Brady WJ. Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus. Am J Med 2005;23:696–703.
  7. Haque S, Bruce In. Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nat Clin Pract Cardiovasc 2005;2:423–8.
  8. Juariah N. Profi le and fi ve year survival analyses of systemic lupus erythematosus patients in Cipto Mangunkusumo General Hospital 1990–2007 [Profi l dan kesintasan lima tahun pada pasien lupus eritematosus sistemik di RSCM tahun 1990-2007]. Theses. University of Indonesia;2008.
  9. Libby P. Infl ammation in atherosclerosis. Nature 2002;420:868–74.
  10. Leuven SP, Castelein JJP, Cruz D, Hughes GR, Stroes ES. Atherogenesis in rheumatology. Lupus 2006;15:117–21.
  11. Rhew EY, Ramsey R. Premature atherosclerosis disease in systemic lupus erythematosus—role of infl ammatory mechanism. Autoimmun Rev 2006;5:101–5.
  12. Jara LJ, Medina G, Lastra OV, Amigo MC. Accelerated atherosclerosis, immune response, and autoimmune rheumatic disease. Autoimmun Rev 2006;5:195–201.
  13. Leeuw K, Kallenberg C, Bijl M. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci 2005;1051:362–71.
  14. Thomas GN, Tam LS, Tomlison B, Li EK. Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the cause and
  15. possible prevention. Hong Kong Med J 2002;8:26–31.
  16. Ross R. Atherosclerosis—an infl ammatory disease. N Engl J Med 1999;340:115–23.
  17. Hahn BH, Grossman J, Chen W, Mc Mahoon M. The pathogenesis of atherosclerosis in autoimmune rheumatic disease: roles of infl ammationand dyslipidemia. J Autoimmun 2007;28:69–75.
  18. Setiawan MA. Assessment of fl ow-mediated dilatation in systemic lupus erythematosus patients. [Penilaian fl ow-mediated dilatation pada penderita lupus eritematosus sistemik]. Theses. University of Indonesia; 2005.
  19. Hahn BH. Systemic lupus erythematosus. N Engl J Med 2003;349:2379–80.
  20. Frostegard J. Atherosclerosis in patients with autoimmune disorder. Arterioscler Thromb Vasc Biol 2005;25:1776–85.
  21. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated
  22. atherosclerosis in systemic lupus erythematosus. Arthritis Rheum2001;44:2331–7.
  23. Bruce IN. ‘Not only ... but also’: factors that contribute to accelerated atherosclerosis and premature coronary disease in systemic lupus erythematosus. Rheumatology 2005;44:1492–502.
  24. Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005;257:485–95.
  25. Alpert D, Davis A, Erkan D, Roman NJ, Salmon JE. Subclinical carotid atherosclerosis in a patient with systemic lupus erythemathosus. Nat Clin Pract Rheumatol 2007;3:473–8.
  26. Wijaya LK. Prevalence of dyslipidemia in systemic lupus erythematosus patients and distribution of its infl uencing factors [Prevalensi dislipidemia pada penderita lupus eritematosus sistemik dan sebaran faktor yang mempengaruhinya]. Theses. University of Indonesia; 2004.
  27. Bulkey BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy, a study of 36 necropsy patients. Am J Med 1975;58:243–63.
  28. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychlorocuine on coronary artery disease risk factor in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254–9.
  29. Soubrier M, Mathieu S, Dubost JJ. Atheroma and systemic lupus erythematosus. Joint Bone Spine 2007;20:1–5.
  30. Roman MJ, Shanker BA, Davis A, Lockhsin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399–406.
  31. Doria A, Shoenfeld Y, Gambari PF, Puato M, Ghirardello A, Gilburd B. Risk factor for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. An Rheum Dis 2003;62:1071–7.
  32. Sato H, Miida T, Wada Y, Maruyama M, Murakami S, Hasegawa H, et al. Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus. Clin Chim Acta 2007;20:1–7.
  33. Selzer F, Tyrrell KS, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, et all. Comparison risk factor for vascular disease in the carotid and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004;50:151–9.
  34. Manzi S, Selzer F, Tyrrell KS, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51–60.
  35. Jimenez S, Garcia-Criado MA, Tassies D, Reverter JC, Cervera R, Gilabert MR. Preclinical vascular disease in systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology 2005;44:756–61.
  36. Petri M, Roubenof R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocystein as a risk factor for atherotrombotic events in systemic lupus erythematosus. Lancet 1996;348:1120–4.
  37. Lee AB, Godfrey K, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, et al. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. J Intern Med 2006;36:237–43.
  38. Chogle AR, Chakravarty A. Cardiovascular events in systemic lupus erythematosus and rhematoid arthritis: emerging concepts, early diagnosis and management. J Assoc Physicians India 2007;55:32–9.
  39. Manzi S. Systemic lupus erythematosus: a model for atherosclerosis. Rheumatology 2000;39:353–9.
  40. Svenungson E, Urstad KJ, Heimburger M, Silveira A, Hamsten A, Faire U, et al. Risk factor for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887–93.
  41. Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Slem A. Markers of infl ammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus. Nephrology 2006;11:329–35.
  42. Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C. Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidemia. Rheumatology 2003;42:758–62.
  43. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantifi cation of degrees of narrowing in 22 necropsy patients aged 16 to 37 years. Am J Med 1981;70:775–81.
  44. MacGregor AJ, Dhillon VB, Binder A. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis 1992;51:152–5.
  45. Wallace DJ, Metger AL, Stecher VJ, Turnbull BA, Kern PA. Cholesterollowering effect of hydroxychlorocuine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipid. Am J Med1990;89:322–6.
  46. Nicolo D, Monestier M. Antiphospholipid antibodies and atherosclerosis. Clin Immunol 2004;112:183–9.
  47. Cederholm A, Frostegard J. Anexin A5 in cardiovascular disease and systemic lupus erythematosus. Immunobiology 2005;210:761–8.
  48. Lusis AJ. Atherosclerosis. Nature 2000;407:233–41.
  49. Touboul TJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Manheim carotid intima-media thickness consensus (2004–2006). Cerebrovasc Dis 2007;23:75–80.
  50. Bots ML, Grobee DE. Intima-media thickness as a surrogate marker for generalized atherosclerosis. Cardiovasc Drugs Ther 2002;16:341–51.
  51. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness. Circulation 2007;115:459–67.
  52. Stein JH. Carotid intima-media thickness and vascular age: you are only as old as your arteries look. J Am Soc Echocardiogr 2004;17:686–9.
  53. Dijk JM, Graaf Y, Bots ML, Grobbee DE. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: The SMART Study. Eur Heart J 2006;27:1971–8.
  54. Amato M, Montorsi P, Ravani A, Oldani E, Galli S, Ravagani PM, et al. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound fi ndings. Eur Heart J 2007;28:2094–101.
  55. Lim TK, Kooner J. Normal value of carotid intima-media thickness—a surrogate marker of atherosclerosis: quantitative assessment by B-mode ultrasound. J Am Soc Echocardiogr 2007;20:1–4.
  56. Cuomo S, Guarini P, Gaeta G, Michele MD, Boeri F, Dorn J, et al. Increased carotid intima-media thickness in children-adolescents, and young adults with a parental history of premature myocardial infarction. Eur Heart J2002;23:1345–50.
  57. Adaikkappan M, Sampath R, Felix AJW, Sethupathy S. Evaluation of carotid atherosclerosis by B-mode ultrasonographic study in hypertensive patient compared with normotensive patient. Ind J Radiology Imaging2002;3:365–8.
  58. Maarifat NN. Thickness of intima-media complex of common carotid artery in group of 20–30 years old patients at Department of Radiology at University of Indonesia School of Medicine/Cipto Mangunkusumo General Hospital [Ketebalan kompleks intima media arteri karotis komunis pada kelompok khusus usia 20–30 tahun di bagian radiologi FKUI-RSCM]. Theses. University of Indonesia; 2005.
  59. Howard G, Sharrett AR, Heis G, Evans GW, Chambless LE, Riley WA, et al. Carotid artery intimal-medial thickness distribution in general population as evaluated by B-mode ultrasound. Stroke 1993;24:1297–304.
  60. Ziembicka AK, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004; 90: 1286–90.